Skip to main content

Day: May 3, 2021

Innovative Payment Solutions, Inc. Announces Appointment of Clifford W. Henry and Madisson G. Corbett to Board of Directors

NORTHRIDGE, CA, May 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Innovative Payment Solutions, Inc. (OTCQB: IPSI) (“Innovative” or the “Company”), a Southern California based fintech company focused on building a 21st century universal digital payment platform, IPSIPay™, today announced the appointment of Clifford W. Henry and Madisson G. Corbett to the Company’s Board of Directors. Following the appointment of Mr. Henry and Ms. Corbett, Innovative’s Board will be comprised of 5 directors, 3 of whom are independent. “We are pleased to welcome Cliff Henry and Madisson Corbett to our Board,” said James Fuller, Director of the Board. “Cliff’s experience in investment management and Madisson’s background working with successful fintech start-ups will be invaluable additions to our team. Moreover, as Innovative continues to...

Continue reading

Schneider vice president named a 2021 “Pro to Know” by Supply & Demand Chain Executive

Mike Kukiela is recognized for excellence in leveraging supply chain for competitive advantage.Mike Kukiela, senior vice president of Supply Chain and Distribution Management at Schneider has been named one of Supply & Demand Chain Executive’s 2021 “Pros to Know.”Green Bay, Wis., May 03, 2021 (GLOBE NEWSWIRE) — Mike Kukiela, senior vice president of Supply Chain and Distribution Management at Schneider, (NYSE: SNDR), a premier provider of trucking, intermodal and logistics services, has been named one of Supply & Demand Chain Executive’s 2021 “Pros to Know.” This award recognizes outstanding executives whose accomplishments leverage supply chains for competitive advantage. This year’s list of “Pros to Know” recognizes individuals and teams from a multitude of industries, including trucking and transportation...

Continue reading

PAVmed to Hold Business Update Conference Call on May 17, 2021

Company conference call and webcast at 4:30 PM EDT NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that the Company will host a business update conference call on Monday, May 17, 2021 at 4:30 PM EDT. During the call, Lishan Aklog, M.D., Chairman and Chief Executive Officer of the Company, will provide a business update including an overview of the Company’s near-term milestones and growth strategy. In addition, Dennis McGrath, the Company’s President and Chief Financial Officer, will discuss first quarter 2021 financial results. To access the conference call, U.S.-based listeners should dial (877) 407-3982 and international listeners should dial (201) 493-6780. All listeners should...

Continue reading

Precipio Launches its Rapid COVID-19 Antibody test on Amazon Platform

Nirmidas’ test is available to POC healthcare providers with an Amazon business account NEW HAVEN, Conn., May 03, 2021 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has successfully launched its COVID-19 rapid antibody test (20 minute) which tests for both IgG & IgM antibodies, on Amazon.com’s business platform. Precipio holds the exclusive rights to distribute this product on Amazon’s platform. The antibody test, which is manufactured in the USA by Nirmidas Biotech, of California, was the first US-based test to receive emergency use authorization (EUA) by the FDA for point-of-care. The product is visible for sale on Amazon’s website and app (click here), per the EUA approval received for the test kit in December of 2020; however it may currently be purchased only by...

Continue reading

iBrands Corporation Becomes Product Sponsor For Professional Football Franchise

LAS VEGAS, May 03, 2021 (GLOBE NEWSWIRE) — iBrands Corporation (OTC PINK: IBRC) (“the Company”), a diversified holding and branding company, announces that through its subsidiary iBrands Farms, has become a product sponsor for the Ontario Bandits Football Club, respectively. The Ontario Bandits became the newest expansion team for the National Arena League (NAL) as the league previously announced recent expansion with the Albany Empire as its New York based franchise this previous October. The Bandits will be the seventh team entering the 2021 season with the NAL joining the Jacksonville Sharks, Columbus Lions, Carolina Cobras, Orlando Predators, Jersey Flight, and the Albany Empire. The company will be providing its immune boosting nutraceutical supplement QuadraMune to the players and staff of the Ontario Bandits...

Continue reading

German Lifestyle Store Returns to Celebros Search by Bridgeline

WOBURN, Mass., May 03, 2021 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), provider of cloud-based marketing technology software, announced a German provider of athleticwear and fashion is once again choosing Celebros to perfect their online experience. This business has over 70 years’ experience in trading history, with a unique mix of assortments that builds bridges between sport and leisure, job and lifestyle. They claim a very special position in the retail landscape with their commitment to current, high-quality fashion and functional sports and outdoor equipment. With their five online shops, the retailer offers a wide spectrum of products for a massive and diverse German audience. This business was a Celebros client until a few years ago when they re-platformed. Recently, the digital team decided to research...

Continue reading

Biofrontera AG: First quarter conference call to be held on May 12, 2021

Leverkusen, Germany, May 03, 2021 (GLOBE NEWSWIRE) — Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its financial results for the first quarter 2021 on Tuesday, May 11, 2021. Conference calls for shareholders and interested investors will be held on Wednesday, May 12, 2021, at the following times: In German, May 12, 2021 at 10:00 am CEST (4:00 am EST)Dial-in number Germany: +49 69201744220Conference code: 60386865# In English, May 12, 2021 at 2:00 pm CEST (8:00 am EST)Dial-in number USA: +1 8774230830Dial-in number UK: +44 2030092470Conference code: 52497289# Please dial in 10 minutes ahead of time to ensure a timely start of the conference call.-End- Biofrontera AGPamela Keck, Head of Investor Relationsir@biofrontera.com+49-214-87632-0 About...

Continue reading

Chicken Soup for the Soul Entertainment Forms Halcyon Television Led by David Ellender

COS COB, Conn., May 03, 2021 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE), one of the leading operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced at the 2021 NewFronts the formation of Halcyon Television. The company will launch Halcyon Television, a high-end premium scripted television studio led by David Ellender as CEO upon the closing of the Sonar asset acquisition that was announced on April 9th, 2020. The closing on the 1,300 title television and film library, scripted development portfolio and the existing TV series drama production is expected to occur in the near future. “The formation of Halcyon Television will help accelerate our company’s strategy to build the leading independent AVOD network in three ways. It will expand our original content...

Continue reading

Revive Therapeutics Enters Into Research Agreement with UCSF For Bucillamine As Potential Treatment For Severe COVID-19

TORONTO, May 03, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, Frankfurt: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into a sponsored research agreement with University of California, San Francisco (“UCSF”) to explore the utility of Bucillamine as a treatment for severe COVID-19. The agreement will support research in the laboratory of Dr. John Fahy to test the efficacy of Bucillamine in pre-clinical models of COVID-19 and to design protocols that test the utility of Bucillamine in human trials. Michael Frank, CEO of Revive commented: “We are excited to expand the use of Bucillamine as a potential treatment for severe COVID-19 with our research...

Continue reading

Genius Brands’ “Stan Lee’s Superhero Kindergarten” Surpasses 9 Million Views on Kartoon Channel!

Schwarzenegger and Exciting Storyline Driving Exponential Growth Across All Key Metrics BEVERLY HILLS, Calif., May 03, 2021 (GLOBE NEWSWIRE) — The April 23 premiere of Genius Brands International, Inc.’s (“Genius Brands”) (NASDAQ:GNUS) Stan Lee’s Superhero Kindergarten, has proven to be a huge hit for Kartoon Channel!, with over 9 million views to date. “Superhero Kindergarten analytics from Kartoon Channel! from the first weekend, exceeded all expectations, with traffic up across every metric we track,” said Kartoon Channel! General Manager, Jon Ollwerther. “Network hours watched went up 941% week-over-week to 349,735 hours. Unique users went up 1,841% week-over-week to 1,858,434 uniques. New application installs went up 465.9%, as we saw growth across all viewing outlets including televisions, tablets, mobile phones, computers,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.